***”The global butanoyl chloride market is set for moderate growth, expanding from roughly $60 million in 2025 to about $92 million by 2032, achieving a CAGR of 6.6%. Dominated by applications in pharmaceutical and pesticide intermediates, the sector sees strongest momentum in Asia-Pacific due to industrial expansion, while North America maintains a solid foothold through advanced chemical manufacturing.”***
Market Overview Butanoyl chloride, a key organic intermediate known for its role in synthesizing esters and amides, continues to benefit from steady demand across chemical synthesis and specialized industries. The compound’s versatility supports its use in producing high-value derivatives, with purity levels of 98% and 99% commanding premium pricing. Global production remains concentrated in cost-efficient facilities, ensuring supply chain resilience amid fluctuating raw material costs.
Global Market Size and Forecast The market’s trajectory reflects balanced expansion driven by downstream sectors. Projections indicate sustained revenue growth, bolstered by innovations in high-purity formulations.
| Year | Market Size (US$ Million) | CAGR (%) |
|---|---|---|
| 2025 | 59.3 | – |
| 2026 | 63.2 | 6.6 |
| 2027 | 67.4 | 6.6 |
| 2028 | 71.8 | 6.6 |
| 2029 | 76.6 | 6.6 |
| 2030 | 81.6 | 6.6 |
| 2031 | 87.0 | 6.6 |
| 2032 | 92.1 | 6.6 |
Regional Analysis Asia-Pacific emerges as the frontrunner, capturing over 40% of global share thanks to robust manufacturing hubs in China and India. North America holds a substantial 25% stake, fueled by pharmaceutical R&D investments. Europe follows with 20%, emphasizing sustainable production practices, while the Middle East and Africa, along with Latin America, account for the remaining 15%, showing potential in emerging agrochemical markets.
Asia-Pacific : Expected to grow at 8% CAGR, propelled by rising pesticide and chemical intermediate production. China leads with expanded facilities, while India’s export-oriented approach adds momentum.
North America : CAGR of 5%, supported by U.S.-based innovations in electronic chemicals and polymers. Canadian contributions focus on raw material integration.
Europe : 6% CAGR, with Germany and France driving demand through strict quality standards in pharma intermediates.
Rest of the World : 7% CAGR in select pockets, particularly in Brazil and Turkey, where agrochemical applications are gaining traction.
| Region | 2025 Share (%) | 2032 Projected Size (US$ Million) | CAGR (%) 2026-2032 |
|---|---|---|---|
| Asia-Pacific | 42 | 42.5 | 8 |
| North America | 25 | 23.0 | 5 |
| Europe | 20 | 18.4 | 6 |
| Rest of World | 13 | 8.2 | 7 |
Key Applications and Segments Pharmaceutical intermediates represent the largest segment at 35%, where butanoyl chloride serves as an acylating agent for drug synthesis. Pesticide intermediates follow at 30%, benefiting from global agricultural needs. Chemical synthesis holds 20%, with the remainder in electronic chemicals and niche uses like perfume production.
High-purity variants (99%) dominate premium applications, growing at 7.5% CAGR.
Low-purity options (98% or below) cater to industrial volumes, expanding at 5.5% CAGR.
Major Players and Competitive Landscape The sector features a mix of established firms and regional specialists. Leading entities include CABB, Excel Industries, and Shiva Pharmachem, which together control about 40% of global output through strategic expansions and R&D focus. Smaller players like Dongying Dafeng Chemical and Huzhou Shalong Chemical emphasize cost-competitive production in Asia. Competitive strategies revolve around supply chain optimization and product differentiation via purity enhancements.
Growth Drivers and Challenges Expansion is fueled by surging pharmaceutical demand amid aging populations and crop protection needs in developing economies. Technological advancements in synthesis processes reduce environmental impact, attracting investments. However, raw material volatility, particularly in butyric acid precursors, poses risks alongside regulatory pressures on hazardous chemicals. Supply disruptions from geopolitical tensions could temper growth, though diversification efforts mitigate these factors.
Disclaimer: This news report is for informational purposes only. Tips and sources are not guaranteed for accuracy or completeness.